These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 20833354)

  • 1. Colorectal cancer screening in an expanding panorama of screening programmes.
    Hoff G
    Best Pract Res Clin Gastroenterol; 2010 Aug; 24(4):521-7. PubMed ID: 20833354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for colorectal cancer.
    Hakama M; Hoff G; Kronborg O; Påhlman L
    Acta Oncol; 2005; 44(5):425-39. PubMed ID: 16118076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Arguments against implementing a population-based screening programme for colorectal cancer].
    Bonneux L
    Ned Tijdschr Geneeskd; 2008 Aug; 152(32):1777. PubMed ID: 18754310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness and economic impact of screening for colorectal cancer by mass fecal occult blood testing.
    Helm JF; Russo MW; Biddle AK; Simpson KN; Ransohoff DF; Sandler RS
    Am J Gastroenterol; 2000 Nov; 95(11):3250-8. PubMed ID: 11095350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrasting US and European approaches to colorectal cancer screening: which is best?
    Hoff G; Dominitz JA
    Gut; 2010 Mar; 59(3):407-14. PubMed ID: 20207645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of primary care in colorectal cancer screening: experience from Czech Republic.
    Seifert B; Zavoral M; Fric P; Bencko V
    Neoplasma; 2008; 55(1):74-80. PubMed ID: 18190246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
    Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
    J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for colorectal cancer screening.
    Bretthauer M
    Best Pract Res Clin Gastroenterol; 2010 Aug; 24(4):417-25. PubMed ID: 20833346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal cancer screening with faecal occult blood test within a multiple disease screening programme: an experience from Keelung, Taiwan.
    Yang KC; Liao CS; Chiu YH; Yen AM; Chen TH
    J Med Screen; 2006; 13 Suppl 1():S8-13. PubMed ID: 17227635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential impact of population-based colorectal cancer screening in Canada.
    Flanagan WM; Le Petit C; Berthelot JM; White KJ; Coombs BA; Jones-McLean E
    Chronic Dis Can; 2003; 24(4):81-8. PubMed ID: 14733756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherence.
    Inadomi JM
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S198-204. PubMed ID: 19120898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High participation rates are not necessary for cost-effective colorectal cancer screening.
    Howard K; Salkeld G; Irwig L; Adelstein BA
    J Med Screen; 2005; 12(2):96-102. PubMed ID: 15949121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis of the optimal threshold of an automated immunochemical test for colorectal cancer screening: performances of immunochemical colorectal cancer screening.
    Berchi C; Guittet L; Bouvier V; Launoy G
    Int J Technol Assess Health Care; 2010 Jan; 26(1):48-53. PubMed ID: 20059780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
    Tsoi KK; Ng SS; Leung MC; Sung JJ
    Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early detection of colorectal cancer with faecal occult blood test screening.
    Paimela H; Malila N; Palva T; Hakulinen T; Vertio H; Järvinen H
    Br J Surg; 2010 Oct; 97(10):1567-71. PubMed ID: 20603855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population-based screening for colorectal cancer: Australian research and implementation.
    Young GP
    J Gastroenterol Hepatol; 2009 Oct; 24 Suppl 3():S33-42. PubMed ID: 19799696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Features of colorectal cancer with fecal-occult-blood tests--comparison with colorectal cancer with no screening].
    Takemasa I; Kikkawa N; Yasui M; Nishisho I; Fujitani K; Mishima H; Hasuike Y; Kobayashi K
    Gan To Kagaku Ryoho; 1998 Aug; 25(10):1514-8. PubMed ID: 9725042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The screening of sporadic colorectal cancer].
    Zavoral M
    Vnitr Lek; 2004 Oct; 50 Suppl 1():S103-6. PubMed ID: 15651152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Screening of high-risk group with colorectal cancer].
    Xu AG; Yu ZJ; Zhong XH; Gan AH; Liu JH; Luo QY
    Zhonghua Yi Xue Za Zhi; 2010 Jan; 90(2):116-8. PubMed ID: 20356496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.